Quinazolines: New horizons in anticonvulsant therapy

European Journal of Medicinal Chemistry

Volumn 80, Issue , 2014, Pages 447-501

  Ugale, Vinod G ^a   Bari, Sanjay B ^b  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^b HR Patel College of Pharmacy   (India)

Author keywords

Anticonvulsant; MES; PTZ induced seizure; Synthesis quinazoline

Indexed keywords

ANTICONVULSIVE AGENT; QUINAZOLINE DERIVATIVE;

ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; CYCLIZATION; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HYDROGEN BOND; LIPOPHILICITY; MOLECULAR MODEL; NONHUMAN; PATENT; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; SYNTHESIS;

ANIMALS; ANTICONVULSANTS; DRUG DESIGN; HUMANS; QUINAZOLINES;

EID: 84899832193     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.04.072     Document Type: Short Survey

References (72)

1. B. Malawska New anticonvulsant agents Current Topics in Medicinal Chemistry 5 2005 69 85
2. G.S. Bell, and J.W. Sander The epidemiology of epilepsy: the size of the problem Seizure: The Journal of the British Epilepsy Association 11 Suppl. A 2002 306 314
3. A.T. Sørensen, and M. Kokaia Novel approaches to epilepsy treatment Epilepsia 54 2013 1 10
4. W. Löscher, and D. Schmidt New horizons in the development of antiepileptic drugs: innovative strategies Epilepsy Research 69 2006 183 272
5. M. Bialer Chemical properties of antiepileptic drugs (AEDs) Advanced Drug Delivery Reviews 64 2012 887 895
6. H.S. White Preclinical development of antiepileptic drugs: past, present and future directions Epilepsia 44 Suppl. 7 2004 2 8
7. D. Schmidt, and M.A. Rogawski New strategies for the identification of drugs to prevent the development or progression of epilepsy Epilepsy Research 50 2002 71 78
8. E. Perucca, J. French, and M. Bialer Development of new antiepileptic drugs: challenges, incentives, and recent advances The Lancet Neuro 6 2007 793 804
9. S. Manjula, E. Bharath, and B. Divya Medicinal and biological significance of quinazoline: a highly important scaffold for drug discovery: a review International Journal of Pharma and Bio Sciences 2 2011 780 809
10. T. Selvam, P. Kumar, and P. Vijayaraj Quinazoline marketed drugs-a review Research in Pharmacy 1 2011 1 21
11. A. Bhaduri, N. Khanna, and M. Dhar Potential anticonvulsants synthesis of 2, 3-disubstituted-4-quinazolinones and quinazolino-4-thiones Indian Journal of Chemistry 2 1964 159 166
12. M.Z.A. Badr, H.A.H. El-Sherief, and A.M. Mahmoud Studies on synthesis of 6-Bromo-2, 3-disubstituted 4-quinazolinones and their thiones Bulletin of the Chemical Society 53 1980 2389 2392
13. A.S. El-Azab, and K.E. ElTahir Design and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activities Bioorganic & Medicinal Chemistry Letters 22 2012 1879 1885
14. V. Alagarsamy, V.R. Solomon, M. Murugan, R. Sankaranarayanan, P. Periyasamy, R. Deepa, and T.D. Anandkumar Synthesis of 3-(2-pyridyl)-2- substituted-quinazolin-4(3H)-ones as new analgesic and anti-inflammatory agents Biomedicine & Pharmacotherapy 62 2008 454 461
15. F. Al-Omary, L. Abou-Zeid, M. Nagi, el.-SE. Habib, A.A. Abdel-Aziz, A.S. El-Azab, S.G. Abdel-Hamide, M.A. Al-Omar, A.M. Al-Obaid, and H.I. El-Subbagh Bioorganic & Medicinal Chemistry 18 2010 2849
16. V. Alagarsamy, V. Raja Solomon, P. Parthiban, K. Dhanabal, S. Murugesan, G. Saravanan, and G. Anjana Synthesis and pharmacological investigation of novel 4-(4-ethyl phenyl)-1-substituted-4H-[1,2,4] triazolo [4,3-a]-quinazolin-5-ones as new class of H1-antihistaminic agents Journal of Heterocyclic Chemistry 45 2008 709 715
17. J. Rosenberg, F. Gustafsson, S. Galatius, and P.R. Hildebrandt Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature Cardiovascular Drugs and Therapy 19 2005 301 306
18. A.J. Barker Quinazoline Derivatives and Their Use as Anti-cancer Agents EP Patent 0,635,498 January 25, 2001
19. M. Zappalà, S. Grasso, N. Micale, G. Zuccalà, F.S. Menniti, G. Ferreri, G. De Sarro, and C. De Micheli 1-Aryl-6,7-methylenedioxy-3H- quinazolin-4-ones as anticonvulsant agents Bioorganic & Medicinal Chemistry Letters 13 2003 4427 4430
20. A. Váradi, P. Horváth, T. Kurtán, A. Mándi, G. Tóth, A. Gergely, and J. Kökösi Synthesis and configurational assignment of 1,2-dihydroimidazo [5,1b] quinazoline-3,9-diones: novel NMDA receptor antagonists Tetrahedron 68 2012 10365 10371
21. V. Colotta, O. Lenzi, D. Catarzi, F. Varano, L. Squarcialupi, C. Costagli, A. Galli, C. Ghelardini, A.M. Pugliese, and G. Maraula 3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: molecular modeling and pharmacological studies European Journal of Medicinal Chemistry 54 2012 470 482
22. J. Almási, K. Takács-Novák, J. Kökösi, and B. Noszál Characterization of potential NMDA and cholecystokinin antagonists I. Acid-base properties of 2-methyl-4-oxo-3H-quinazoline-3-alkyl- carboxylic acids at the molecular and submolecular levels International Journal of Pharmaceutics 180 1999 1 11
23. F. Varano, D. Catarzi, V. Colotta, O. Lenzi, G. Filacchioni, A. Galli, and C. Costagli Novel AMPA and kainate receptor antagonists containing the pyrazolo [1,5] quinazoline ring system: synthesis and structure activity relationships Bioorganic & Medicinal Chemistry 16 2008 2617 2626
24. V. Jatav, P. Mishra, S. Kashaw, and J. Stables Synthesis and CNS depressant activity of some novel 3-[5-substituted1,3,4-thiadiazole-2-yl]-2- styryl quinazoline-4(3H)-ones European Journal of Medicinal Chemistry 43 2008 135 141
25. A.S. El-Azab, K.E. ElTahir, and S.M. Attia Synthesis and anticonvulsant evaluation of some novel 4 (3H)-quinazolinones Monatshefte für Chemie-Chemical Monthly 142 2011 837 848
26. R. Misra, A. Chaturvedi, N. Rao, and S. Parmar Anticonvulsant and monoamine oxidase inhibitory properties of newer chlorostrylquinazolones Pharmacological Research Communications 11 1979 623 633
27. J. Nilsson, R. Gidlöf, E. Nielsen, T. Liljefors, M. Nielsen, and O. Sterner Triazoloquinazolinediones as novel high affinity ligands for the benzodiazepine site of GABA receptors Bioorganic & Medicinal Chemistry 19 2011 111 121
28. P. Kahnberg, M.H. Howard, T. Liljefors, M. Nielsen, E. Nielsen, O. Sterner, and I. Pettersson The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABA receptor Journal of Molecular Graphics & Modelling 23 2004 253 261
29. D. Catarzi, O. Lenzi, V. Colotta, F. Varano, D. Poli, G. Filacchioni, K. Lingenhöhl, and S. Ofner Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo [1,5-a] quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4- yl)-propionic acid receptor antagonists Chemical & Pharmaceutical Bulletin 58 2010 908 911
30. H. Rajak, B.S. Thakur, P. Kumar, P. Parmar, P.C. Sharma, R. Veerasamy, and M.D. Kharya Synthesis and antiepileptic activity of some novel semicarbazones containing 1,3,4-thiadiazole and quinazoline ring Acta Poloniae Pharmaceutica 69 2012 253 261
31. H.J. Wang, C.X. Wei, X.Q. Deng, F.L. Li, and Z.S. Quan Synthesis and evaluation on anticonvulsant and antidepressant activities of 5-alkoxy-tetrazolo [1,5-a] quinazolines Archives of Pharmacal Research 342 2009 671 675
32. C.O. Usifoh, and G.K. Scriba Synthesis and anticonvulsant activity of acetylenic quinazolinone derivatives Archives of Pharmacal Research 333 2000 261 266
33. Y. Zheng, M. Bian, X.Q. Deng, S.B. Wang, and Z.S. Quan Synthesis and anticonvulsant activity evaluation of 5-Phenyl-[1,2,4]triazolo[4,3-c]quinazolin- 3-amines Archives of Pharmacal Research 346 2012 119 126
34. A.A. Kadi, A.S. El-Azab, A.M. Alafeefy, and S. Abdel-Hamide Synthesis and biological screening of some new substituted 2-Mercapto-4-(3H)-quinazolinone analogs as anticonvulsant agents Arizona Journal of Pharmaceutical Science 34 2009 135 155
35. D. Orain, S. Ofner, M. Koller, D.A. Carcache, W. Froestl, H. Allgeier, V. Rasetti, J. Nozulak, H. Mattes, and N. Soldermann 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists Bioorganic & Medicinal Chemistry Letters 22 2012 996 999
36. A. El-Helby, and M. Wahab Design and synthesis of some new derivatives of 3H-quinazolin-4-one with promising anticonvulsant activity Acta Pharmaceutica 53 2003 127
37. F. Varano, D. Catarzi, V. Colotta, F.R. Calabri, O. Lenzi, G. Filacchioni, A. Galli, C. Costagli, F. Deflorian, and S. Moro 1-Substituted pyrazolo [1,5H] quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation, and molecular modeling study Bioorganic & Medicinal Chemistry 13 2005 5536 5549
38. G. Saravanan, V. Alagarsamy, and C.R. Prakash Design, synthesis and anticonvulsant activities of novel 1-(substituted/unsubstituted benzylidene)-4-(4-(6,8-dibromo-2-(methyl/phenyl)-4-oxoquinazolin-3(4H)-yl) phenyl) semicarbazide derivatives Bioorganic & Medicinal Chemistry Letters 22 2012 3072 3078
39. I.-K. Lee, B.-S. Yun, G. Han, D.-H. Cho, Y.-H. Kim, and I.-D. Yoo Dictyoquinazols A, B, and C, new neuroprotective compounds from the mushroom Dictyophora indusiata Journal of Natural Products 65 2002 1769 1772
40. H.C. Jackson, H.C. Hansen, M. Kristiansen, P.D. Suzdak, H. Klitgaard, M.E. Judge, and M.D. Swedberg Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice European Journal of Pharmacology 308 1996 21 30
41. J.E. Francis, W.D. Cash, B.S. Barbaz, P.S. Bernard, R.A. Lovell, G.C. Mazzenga, R.C. Friedmann, J.L. Hyun, A.F. Braunwalder, P.S. Loo, and D.A. Bennett Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c] quinazoline-5(6H)-ones Journal of Medicinal Chemistry 34 1991 281 290
42. C. Gupta, A. Bhaduri, and N. Khanna Drugs acting on the central nervous system. Syntheses of substituted quinazolinones and quinazolines and triazepino-triazocinoquinazolinones Journal of Medicinal Chemistry 11 1968 392 395
43. N.A. Vaidya, C. Panos, A. Kite, W.B. Iturrian, and C.D. Blanton Jr. Synthesis of 3,4-dihydro-4-oxoquinazoline derivatives as potential anticonvulsants Journal of Medicinal Chemistry 26 1983 1422 1425
44. A.A. Fatmi, N.A. Vaidya, W. Iturrian, and C.D. Blanton Jr. Synthesis of previously inaccessible quinazolines and 1,4-benzodiazepines as potential anticonvulsants Journal of Medicinal Chemistry 27 1984 772 778
45. F. Varano, D. Catarzi, V. Colotta, G. Filacchioni, A. Galli, C. Costagli, and V. Carlà Synthesis and biological evaluation of a new set of pyrazolo [1,5-c] quinazoline-2-carboxylates as novel excitatory amino acid antagonists Journal of Medicinal Chemistry 45 2002 1035 1044
46. W. Welch, F. Ewing, J. Huang, F. Menniti, M. Pagnozzi, K. Kelly, P. Seymour, V. Guanowsky, S. Guhan, and M. Guinn Atropisomeric quinazolin-4-one derivatives are potent noncompetitive α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptor antagonists Bioorganic & Medicinal Chemistry Letters 11 2001 177 181
47. V. Colotta, D. Catarzi, F. Varano, O. Lenzi, G. Filacchioni, C. Costagli, A. Galli, C. Ghelardini, N. Galeotti, and P. Gratteri Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. synthesis, pharmacological, and molecular modeling studies Journal of Medicinal Chemistry 49 2006 6015 6026
48. V. Colotta, D. Catarzi, F. Varano, G. Filacchioni, L. Cecchi, A. Galli, and C. Costagli Synthesis and binding activity of some pyrazolo [1, 5-c] quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand Journal of Medicinal Chemistry 39 1996 2915 2921
49. M. Koller, K. Lingenhoehl, M. Schmutz, I.-T. Vranesic, J. Kallen, Y.P. Auberson, D.A. Carcache, H. Mattes, S. Ofner, and D. Orain Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity Bioorganic & Medicinal Chemistry Letters 21 2011 3358 3361
50. B. Chenard, F. Menniti, M. Pagnozzi, K. Shenk, F. Ewing, and W. Welch Methaqualone derivatives are potent noncompetitive AMPA receptor antagonists Bioorganic & Medicinal Chemistry Letters 10 2000 1203 1205
51. V.G. Ugale, H.M. Patel, S.G. Wadodkar, S.B. Bari, A.A. Shirkhedkar, and S.J. Surana Quinazolino-benzothiazoles: fused pharmacophores as anticonvulsant agents European Journal of Medicinal Chemistry 53 2012 107 113
52. M.M. Aly, Y.A. Mohamed, K.A. El-Bayouki, W.M. Basyouni, and S.Y. Abbas Synthesis of some new 4-(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities part-1 European Journal of Medicinal Chemistry 45 2010 3365 3373
53. P. Kumar, B. Shrivastava, S.N. Pandeya, and J.P. Stables Design, synthesis and potential 6 Hz psychomotor seizure test activity of some novel 2-(substituted)-3-[substituted]aminoquinazolin-4(3H)-one European Journal of Medicinal Chemistry 46 2011 1006 1018
54. R. Goel, V. Kumar, and M. Mahajan Quinazolines revisited: search for novel anxiolytic and GABAergic agents Bioorganic & Medicinal Chemistry Letters 15 2005 2145 2148
55. S.K. Kashaw, V. Kashaw, P. Mishra, N. Jain, and J. Stables Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea European Journal of Medicinal Chemistry 44 2009 4335 4343
56. U. Kabra, C. Chopde, and S. Wadodkar Design and synthesis of new derivatives of 3H-Quinazolin-4-one as potential anticonvulsant agents Journal of Heterocyclic Chemistry 48 2011 1351
57. V. Jatav, P. Mishra, S. Kashaw, and J. Stables CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl] -2-styryl quinazoline-4(3H)-ones European Journal of Medicinal Chemistry 43 2008 1945 1954
58. V. Colotta, D. Catarzi, F. Varano, F.R. Calabri, G. Filacchioni, C. Costagli, and A. Galli 3-Hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists Bioorganic & Medicinal Chemistry Letters 14 2004 2345 2349
59. T. Panneerselvam, P.V. Kumar, C.R. Prakash, and S. Raja Synthesis and anticonvulsant activity of 6,7,8,9-tetrahydro-5H-5-(2′-hydroxy phenyl)-2-(4′-substituted benzylidine)-3-(4-nitrophenyl amino) thiazolo quinazoline derivatives Toxicological & Environmental Chemistry 93 2011 643 655
60. H. Georgey, N. Abdel-Gawad, and S. Abbas Synthesis and anticonvulsant activity of some quinazolin-4-(3H)-one derivatives Molecules 13 2008 2557 2569
61. A. Rajasekaran, V. Rajamanickam, and S. Darlinquine Synthesis of some new thioxoquinazolinone derivatives and a study on their anticonvulsant and antimicrobial activities European Review for Medical and Pharmacological Sciences 17 2013 95 104
62. S.-S. Abbas, F.M. Awadallah, N.A. Ibrahim, E.G. Said, and G. Kamel Design and synthesis of some 3-Substituted-2-[(2,4-dichlorophenoxy)-methyl] quinazolin-4(3H)-one derivatives as potential anticonvulsant agents Chemical & Pharmaceutical Bulletin 61 2012 679 687
63. M. Prashanth, M. Madaiah, H. Revanasiddappa, and B. Veeresh Synthesis, anticonvulsant, antioxidant and binding interaction of novel N-substituted methylquinazoline-2,4 (1H,3H)-dione derivatives to bovine serum albumin: a structure-activity relationship study Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 110 2013 324 333
64. F. Varano, D. Catarzi, V. Colotta, D. Poli, G. Filacchioni, A. Galli, and C. Costagli Synthesis and biological evaluation of a new set of pyrazolo [1,5-c] quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists Chemical & Pharmaceutical Bulletin 57 2009 826 829
65. P. Floersheim, H. Allgeier, W. Froestl, M. Koller, H. Mattes, J. Nozulak, S. Ofner, D. Orain, V. Rasetti, and J. Renaud Quinazoline Derivatives EP Patent 1,773,788 November 14, 2012
66. R. Upasani, X. Cai, N.C. Lan, Y. Wang, G. Field, and D.B. Fick Substituted Quinazolines and Analogs and the Use Thereof EP Patent 1,066,039 January 10, 2001
67. D. Wilson, L. Fanning, P. Krenitsky, and J. Boger Quinazolines Useful as Modulators of Ion Channels U.S. Patent 7,718,658 May 18, 2010
68. W. Thompson 2-Cyclohexyl Quinazoline NMDA/NR2B Antagonists U.S. Patent 6,380,205 April 30, 2002
69. B.L. Chenard, and W.M. Welch Quinazoline-4-one AMPA Antagonists EP Patent 0,884,316 September 30, 2002
70. P. Chen, A. Hutchison, and G. Cai Imidazol [1,5-c] Quinazolines; a New Class of GABA Brain Receptor U.S. Patent 6,103,731 August 15, 2000
71. H. Allgeier, J. Nozulak, D. Orain, J. Renaud, Y. Auberson, D. Carcache, P. Floersheim, C. Guibourdenche, W. Froestl, and J. Kallen 1H-Quinazoline-2,4- diones and Their Use as AMPA-receptor Ligands EP Patent 2,463,278 January 13, 2012
72. W.M. Welch, and K.M. Devries Atropisomers of 3-aryl-4(3H)-quinazolinones and Their Use as AMPA-receptor Antagonists EP Patent 0,968,194 May 26, 2004